Phillip Saccone

Deficits in Dopamine D2 Receptors and Presynaptic Dopamine in Heroin Dependence: Commonalities and Differences with Other Types of Addiction

Diana Martínez, Phillip Saccone, Fei Liu et al. · Biological Psychiatry · 2011 · 158 citations

Medicine, Neuroscience, Pharmacology +17

The effects of ibudilast, a glial activation inhibitor, on opioid withdrawal symptoms in opioid-dependent volunteers

Ziva D. Cooper, Kirk W. Johnson, Martina Pavlicová et al. · Addiction Biology · 2015 · 149 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine‐maintained intravenous heroin abusers

Sandra D. Comer, Maria A. Sullivan, Suzanne K. Vosburg et al. · Addiction · 2010 · 103 citations

Medicine, Pharmacology, Pharmacotherapy +15

Effects of Acute Oral Naltrexone on the Subjective and Physiological Effects of Oral D-Amphetamine and Smoked Cocaine in Cocaine Abusers

Sandra D. Comer, Shanthi Mogali, Phillip Saccone et al. · Neuropsychopharmacology · 2013 · 53 citations · Full text

Medicine, Behavioral Sciences, Pharmacology +14

Relationship between rate of infusion and reinforcing strength of oxycodone in humans

Sandra D. Comer, Judy Ashworth, Maria A. Sullivan et al. · Journal of Opioid Management · 2018 · 53 citations

Medicine, Pharmacology, Behavioral Pharmacology +11